US opioid crisis: Purdue Pharma in the spotlight
It has been reported that in 2017 around 72,000 Americans died from drug overdoses, many from opiates. The company receiving the most attention is Purdue Pharma, run by the Sackler…
It has been reported that in 2017 around 72,000 Americans died from drug overdoses, many from opiates. The company receiving the most attention is Purdue Pharma, run by the Sackler…
Founded in 1998, GW Pharmaceuticals is a true pioneer in cannabinoid medicines and the only pharmaceutical company with a license to cultivate cannabis in the UK. “While people were wary…
It is said that ostriches have the strongest immune system of any animal in the world. Because of this, they have shown great promise in preventative healthcare in humans and…
Theranos the US biotech start-up is to be dissolved after bad-blood tests exposed. Theranos was set up in Silicon Valley in 2004 by 19-year-old founder Elizabeth Holmes who was considered…
A confluence of factors – urbanisation, industrialisation, poor eating habits and a sedentary lifestyle – have triggered a surge in noncommunicable diseases (NCDs) in Algeria. NCDs now account for 76…
Novartis receives NHS approval for their CAR T-cell therapy to treat leukaemia in children, 10 days after receiving European Commission (EC) approval. “It’s fantastic news for children and young people with this…
Dr Carlos Macaya received worldwide recognition as a cardiovascular surgeon after he operated on the tender heart of Mother Teresa. Now, as the President of the Spanish Heart Foundation, he…
As cannabis in Canada cruises towards legalization, Pharma giants race for patented products. Big Pharma is establishing a significant cannabis presence in Canada with registered patents in advance of…
The European Medicines Agency has cut Britain out of its contracts 7 months ahead of Brexit. “You might have been working on a cancer drug for decades and built up…
KaNDy Therapeutics, a UK-based biotech has raised £25 million to finance the Phase 2b trial of their breakthrough product in Women’s Health. Our investors and the KaNDy management team are united…
This week Novartis received approval from the European Commission (EC) for Kymriah, their chimeric antigen receptor T cell (CAR-T) therapy for young people under 25 with cancer of the blood. Leading the…
With Spain now on the road to economic recovery following the ravages of the global financial crisis, multinational pharmaceutical companies are seeing the country as a top investment destination once…
See our Cookie Privacy Policy Here
